# OnCo record nct06982521 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06982521/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06982521", "NCT06982521" ;
  schema:name "Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer"@en ;
  schema:alternateName "ReDiscover-2"@en ;
  schema:description "A phase 3 trial testing Zovegalisib in HR-positive / HER2-negative breast cancer, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06982521/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06982521> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "3" ;
  schema:startDate "2025-08-26" ;
  onco:cancers <https://onco.cc/cancers/breast-hr-positive/>, <https://onco.cc/cancers/hr-positive-metastatic-post-cdk46/> ;
  onco:drugs <https://onco.cc/drugs/zovegalisib/> ;
  onco:companies <https://onco.cc/companies/relay-therapeutics/> .